MedPath

PET-CT Imaging Features of Meibomian Glands

Recruiting
Conditions
Dry Eye
MGD-Meibomian Gland Dysfunction
Positron-Emission Tomography
Registration Number
NCT06324890
Lead Sponsor
Zhongnan Hospital
Brief Summary

Analysis the results of Dry eye analysis results and PET-CT imaging comprehensively

Detailed Description

Medical records of patients who visited the ophthalmology department between January 2021 and December 2023 and had a PET-CT examination in our hospital within one month were collected. The dry eye analysis results of all patients were collected, and the lacrimal river height, tear film rupture time and meibomian gland grade were counted. The results of PET-CT were collected and the SUV values of the tarsal gland were calculated.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Patients who visited the ophthalmology Department of Zhongnan Hospital from January 2021 to December 2023 and had a PET-CT examination in the hospital within one month
Exclusion Criteria
  • Dry eye analysis was not performed
  • History of eye surgery or trauma
  • Other systemic diseases affecting the eyes

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Tear-film lipid layer thicknessWithin a month of the PET imaging

Measured by dry eye analyzer machine

Lacrimal river heightWithin a month of the PET imaging

Measured by dry eye analyzer machine

Tear break-up timeWithin a month of the PET imaging

Measured by dry eye analyzer machine

Meibomian glands two-dimensional digital infrared imagesWithin a month of the PET imaging

Measured by dry eye analyzer machine

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Zhongnan Hospital of Wuhan University

🇨🇳

Wuhan, Hubei, China

© Copyright 2025. All Rights Reserved by MedPath